Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study

Background Information is needed on the safety of adalimumab when used in pregnancy for the treatment of certain autoimmune diseases. Methods and findings Between 2004 and 2016, the Organization of Teratology Information Specialists Research Center at the University of California San Diego conducted...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Christina Chambers, Diana L. Johnson, Ronghui Xu, Yunjun Luo, Janina Lopez-Jimenez, Margaret P Adam, Stephen R. Braddock, Luther K. Robinson, Keith K. Vaux, Kenneth Lyons Jones
Formato: Artigo
Idioma:inglés
Publicado: 2019
Acceso en liña:https://doi.org/10.1371/journal.pone.0223603
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0223603&type=printable
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!